BioCentury
ARTICLE | Clinical News

Angiomax vs Heparin data released

September 4, 2001 7:00 AM UTC

The Medicines Co. (MDCO) reported results of HERO-2, a randomized, open label Phase IIIb trial comparing the company's Angiomax bivalirudin with heparin in 17,073 patients receiving fibrinolysis for m...